Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV -1 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01009762
What this trial is testing

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection

Who this might be right for
HIV INFECTIONS
Gitte Kronborg 11
Very early researchUnknownNCT03174977
What this trial is testing

Pharmacokinetics Distribution of Raltegravir by PET/MR

Who this might be right for
HIV-1-infection
University of California, San Francisco 10
Large-scale testing (Phase 3)Study completedNCT00363142
What this trial is testing

An Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 211
Not applicableStudy completedNCT04772469
What this trial is testing

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections+5 more
University of California, San Francisco 934
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Testing effectiveness (Phase 2)Study completedNCT01725542
What this trial is testing

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Who this might be right for
HCV-HIV Co-Infection
ANRS, Emerging Infectious Diseases 75
Testing effectiveness (Phase 2)Study completedNCT00530777
What this trial is testing

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Who this might be right for
HIV InfectionsHerpes Simplex
University of Washington 148
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT04802811
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

Who this might be right for
HIV-1 Infection
Jiangsu HengRui Medicine Co., Ltd. 37
Large-scale testing (Phase 3)Study completedNCT00120393
What this trial is testing

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Who this might be right for
HIV Infections
Bristol-Myers Squibb 192
Not applicableStudy completedNCT02191332
What this trial is testing

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Who this might be right for
HIV Infections
Boehringer Ingelheim 147
Early research (Phase 1)Study completedNCT02599896
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
Prevention of HIV InfectionHIV AntibodiesMonoclonal Antibody, Human+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Post-approval studies (Phase 4)Study completedNCT00207142
What this trial is testing

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 252
Not applicableStudy completedNCT03579381
What this trial is testing

Specimen Repository for HIV Immunopathogenesis

Who this might be right for
HIV-1-infectionAcute HIV Infection
AIDS Healthcare Foundation 9
Post-approval studies (Phase 4)Study completedNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Study completedNCT00990600
What this trial is testing

QoL and Adherence to One-pill Once-a-day HAART

Who this might be right for
HIV InfectionHIV Infections
A.O. Ospedale Papa Giovanni XXIII 212
Next Page